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Abstract. 
 
The AP-1 adaptor complex is associated with 
the TGN, where it links selected membrane proteins to 
the clathrin lattice, enabling these proteins to be con-
centrated in clathrin-coated vesicles. To identify other 
proteins that participate in the clathrin-coated vesicle 
cycle at the TGN, we have carried out a yeast two-
hybrid library screen using the 
 
g
 
-adaptin subunit of
the AP-1 complex as bait. Two novel, ubiquitously ex-
pressed proteins were found: p34, which interacts with 
both 
 
g
 
-adaptin and 
 
a
 
-adaptin, and 
 
g
 
-synergin, an alter-
natively spliced protein with an apparent molecular 
 
mass of 
 
z
 
110–190 kD, which only interacts with
 
g
 
-adaptin. 
 
g
 
-Synergin is associated with AP-1 both in 
the cytosol and on TGN membranes, and it is strongly 
enriched in clathrin-coated vesicles. It binds directly to 
the ear domain of 
 
g
 
-adaptin and it contains an Eps15 
homology (EH) domain, although the EH domain is 
not part of the 
 
g
 
-adaptin binding site. In cells express-
ing 
 
a
 
-adaptin with the 
 
g
 
-adaptin ear, a construct that 
goes mainly to the plasma membrane, much of the
 
g
 
-synergin is also rerouted to the plasma membrane,
indicating that it follows AP-1 onto membranes rather 
than leading it there. The presence of an EH domain 
suggests that 
 
g
 
-synergin links the AP-1 complex to an-
other protein or proteins.
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T
 
HE
 
 coats on clathrin-coated vesicles are assembled
from two components, clathrin and adaptor com-
plexes or APs, both of which must be recruited from
the cytosol onto the appropriate membrane. Two adaptor
complexes have been identified on clathrin-coated vesi-
cles, AP-1, which is associated with the TGN, and AP-2,
which is associated with the plasma membrane. Both com-
plexes are heterotetramers, consisting of two large sub-
units or adaptins (
 
g
 
 and 
 
b
 
1 in the case of AP-1, 
 
a
 
 and 
 
b
 
2 in
the case of AP-2), a medium-sized subunit (
 
m
 
1 or 
 
m
 
2), and
a small subunit (
 
s
 
1 or 
 
s
 
2) (Robinson, 1997).
A number of additional peripheral membrane proteins
are now known to be involved in clathrin-coated vesicle
formation at the plasma membrane, and most of these
have been shown to bind either directly or indirectly to the
COOH-terminal ear domain of the 
 
a
 
-adaptin subunit of
the AP-2 complex. These include amphiphysin, which
binds directly to the 
 
a
 
-adaptin ear (David et al., 1996), and
dynamin, which binds to amphiphysin and possibly also di-
rectly to the 
 
a
 
-adaptin ear (Wang et al., 1995; David et al.,
1996). Two other amphiphysin binding partners are synap-
tojanin (DeHeuvel et al., 1997) and endophilin, a protein
that interacts with synaptojanin as well as with amphi-
physin (Micheva et al., 1997). Dynamin is a GTPase that
may be involved in the pinching off of the vesicle from the
plasma membrane, whereas synaptojanin is an inositol
5-phosphatase. The exact functions of amphiphysin and en-
dophilin are unknown, other than that they each have two
or more binding partners. Another protein that binds di-
rectly to the 
 
a
 
-adaptin ear is Eps15 (Benmerah et al., 1996;
Iannolo et al., 1997), first identified as a substrate for the
EGF receptor tyrosine kinase (Fazioli et al., 1993; Wong et
al., 1995). Eps15 contains three copies of a motif known as
an EH
 
1
 
 (for Eps15 homology) domain (Wong et al., 1995),
which has been shown to bind to sequences containing the
tripeptide NPF (Salcini et al., 1997). One of the isoforms
of synaptojanin contains three NPF sequences, making it a
potential binding partner for Eps15, and there is more di-
rect evidence for an interaction between the EH domains
of Eps15 and the NPF-containing protein epsin (Chen et
al., 1998). In addition, epsin has been shown to bind di-
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rectly to the 
 
a
 
-adaptin ear (Chen et al., 1998). There is also
some evidence that epsin binds to the EH domain-contain-
ing proteins Ese1 and Ese2, the vertebrate homologues of
the 
 
Drosophila
 
 protein Dap160, recently identified as a
dynamin binding partner (Roos and Kelly, 1998; Sengar et
al., 1999). Thus, although clathrin and adaptors are the
most abundant components of clathrin-coated vesicles, it
is now apparent that there are many additional proteins
involved in clathrin-coated vesicle formation, at least at
the plasma membrane, which may act in an orderly se-
quence to drive the process forward.
Clathrin-coated vesicle formation is likely to be just as
complex at the TGN as at the plasma membrane. How-
ever, so far no accessory molecules have been identified
that interact either directly or indirectly with the AP-1
complex. Part of the reason may be that many of the pro-
teins described above were originally purified and charac-
terized as abundant components of nerve terminals, where
AP-2 and clathrin are also concentrated because of the
enormous amount of endocytosis that must take place in
the nerve terminal to recycle synaptic vesicle components.
In this study, we set out to identify novel AP-1 binding
partners, specifically those that interact with the 
 
g
 
-adaptin
subunit. We were particularly interested in proteins that
might participate in the recruitment of AP-1 onto the
TGN membrane. Experiments making use of chimeras be-
tween 
 
g
 
- and 
 
a
 
-adaptin have shown that these subunits
contain at least some of the targeting information (Robin-
son, 1993; Page and Robinson, 1995). We also hoped to
find proteins that might participate in a complex network
of interactions involving the AP-1 complex, similar to the
one described for the AP-2 complex. The approach that
we used was to carry out a yeast two-hybrid library screen,
using full-length 
 
g
 
-adaptin as bait. Here we report the dis-
covery of a novel 
 
g
 
-adaptin binding partner, which inter-
acts with the COOH-terminal ear domain and may act as
an adaptor adaptor, connecting the AP-1 complex to other
proteins in the same way that amphiphysin, Eps15, and
epsin are thought to connect the AP-2 complex to proteins
such as dynamin and synaptojanin.
 
Materials and Methods
 
Library Screening
 
A Matchmaker rat brain cDNA library in pGAD10 was purchased from
CLONTECH Laboratories and screened according to the manufacturer’s
instructions. The construct used as bait was full-length 
 
g
 
-adaptin in the
vector pGBT9 (Page and Robinson, 1995). The colonies were allowed to
grow for 8 d on plates lacking tryptophan, leucine, and histidine, and then
replica plated and assayed for 
 
b
 
-galactosidase activity. Positive colonies
were grown in medium lacking tryptophan but containing leucine and his-
tidine and tested for loss of the pGBT9-
 
g
 
-adaptin plasmid, and then reas-
sayed for 
 
b
 
-galactosidase activity. Only those colonies that tested negative
were analyzed further.
Plasmid DNA was isolated from eight representative colonies, trans-
formed into 
 
Escherichia coli
 
 TG2 cells, and analyzed by sequencing and
Southern blotting (Sambrook et al., 1989). To find out whether the re-
maining yeast colonies contained the same plasmids as the test colonies,
colony blots were prepared using Hybond-N
 
1
 
 nylon membranes. The
membranes were placed on a plate of colonies, transferred (colony side
up) onto filter paper soaked in 1 M sorbitol, 0.1 M sodium citrate, pH 7.0,
50 mM EDTA, and 15 mM DTT containing 2 mg/ml yeast lytic enzyme
(ICN Biochemicals), and incubated overnight at 30
 
8
 
C. Lysis of the cells
was completed by incubating the membranes on filter paper soaked with
 
10% SDS for 5 min. The membranes were treated with NaOH to denature
the DNA, neutralized, and alkali fixed (Sambrook et al., 1989). Prehybrid-
ization, hybridization, and washing were carried out as previously de-
scribed (Robinson, 1989, 1990).
The constructs obtained from the library screen were all tested to de-
termine whether they interacted with any of the other adaptor subunits
(Page and Robinson, 1995), and the p34 clone was found to interact with
 
a
 
-adaptin as well as 
 
g
 
-adaptin. To determine whether the binding sites for
p34 on the two adaptins mapped to their NH
 
2
 
-terminal domains, both
constructs were digested with ApaI, which cuts just upstream from the
hinge, end repaired, and digested with EcoRI, which cuts at the 5
 
9
 
 end,
and ligated into pGBT9 digested with EcoRI and SmaI. The resulting con-
structs were cotransformed with the p34 clone (in pGAD424) into host
cells, and the colonies were assayed for 
 
b
 
-galactosidase activity.
To obtain the complete coding sequence of 
 
g
 
-synergin, a probe was
prepared from the clone obtained in the two-hybrid library screen by ran-
dom priming and was used to screen a rat brain cDNA library in 
 
l
 
gt10
(CLONTECH Laboratories). Library screening, subcloning, and charac-
terization of the clones were all carried out as previously described (Rob-
inson, 1989, 1990). The expressed sequence tag (EST) database was also
searched and three human cDNAs were identified (clone I.D. numbers
510825, 565380, and 51509). These three clones were obtained from the
IMAGE Consortium and sequenced in their entirety in both directions,
using oligonucleotide primers. In addition, a search of the nonredundant
database revealed a partial human genomic sequence for 
 
g
 
-synergin (ac-
cession number AC004099), which enabled us to confirm the EST se-
quences and to identify the exon-intron boundaries, including the alterna-
tive splice sites.
 
Northern Blotting
 
A rat multiple tissue Northern blot was purchased from CLONTECH
Laboratories and probed according to the manufacturer’s instructions.
The probe for p34 was the insert from one of the clones from the two-
hybrid screen, containing the full coding sequence, whereas the probe for
 
g
 
-synergin was the insert from the single clone identified in the two-hybrid
screen, which encodes the NH
 
2
 
-terminal portion of the protein (see be-
low). Both inserts were labeled with [
 
32
 
P]dCTP by random priming (Sam-
brook et al., 1989).
 
Antibody Production
 
Antibodies were raised against a GST-
 
g
 
-synergin fusion protein, using the
expression vector pGEX3X (Pharmacia). PCR was used to introduce
SmaI and EcoRI sites into the insert from the original rat 
 
g
 
-synergin clone
(corresponding to amino acids 168–786 of the full-length protein, but
missing amino acids 197–274, presumably because the protein is alterna-
tively spliced) so that it could be expressed in the appropriate reading
frame. The construct was soluble and was purified on GSH-Sepharose
(Pharmacia) according to the manufacturer’s instructions. Immunization
and affinity purification of the resulting antisera were carried out as previ-
ously described (Page and Robinson, 1995). In brief, two rabbits were in-
jected with 0.5 mg of fusion protein in complete Freund’s adjuvant, fol-
lowed by boosts of 0.5 mg fusion protein in incomplete Freund’s adjuvant
at 2 and 8 wk after the primary injection. 10 d after the final injection, the
rabbits were bled out and preimmune and immune sera were tested on
blots of the fusion protein. Both immune sera were found to give a strong
signal, whereas no signal was obtained with the preimmune sera. The anti-
sera were absorbed with GST and affinity-purified with GST-fusion pro-
tein, and then the affinity-purified antisera were absorbed again with GST
(Page and Robinson, 1995).
 
Immunoprecipitation and Western Blotting
 
Immunoprecipitation of coat proteins from rat liver cytosol was carried
out under nondenaturing conditions as previously described (Page and
Robinson, 1995; Seaman et al., 1996). The antibodies included affinity-
purified anticlathrin heavy chain, anti–
 
g
 
-adaptin, and anti–
 
a
 
-adaptin (Ball
et al., 1995; Seaman et al., 1996; Simpson et al., 1996), and the affinity-
purified antibody against 
 
g
 
-synergin described above. Western blotting
was carried out as previously described (Robinson and Pearse, 1986). The
affinity-purified anti–
 
g
 
-synergin was used at 1:500.
 
Immunofluorescence
 
Madin Darby bovine kidney cells were grown on multiwell test slides, 
Page et al. 
 
g
 
-Synergin, a 
 
g
 
-Adaptin–binding Protein
 
995
 
fixed with methanol and acetone, and prepared for immunofluorescence
as previously described (Robinson, 1987). For some experiments, before
fixation the cells were treated with 5 
 
m
 
g/ml brefeldin A (Sigma Chemical
Co.), and then either fixed immediately or washed in fresh medium and al-
lowed to recover. To examine the distribution of 
 
g
 
-synergin in cells ex-
pressing the chimeric adaptin 
 
gga
 
, stably transfected Rat1 cells (Robin-
son, 1993) were fixed as above. The fixed cells were incubated with mouse
anti–
 
g
 
-adaptin mAb100/3 (Sigma Chemical Co.) (Ahle et al., 1988), which
interacts both with the endogenous (nonrodent) 
 
g
 
-adaptin in the MDBK
cells and with the chimeric construct in the transfected Rat1 cells, together
with affinity-purified rabbit anti–
 
g
 
-synergin, followed by fluorescein-
labeled donkey anti–rabbit IgG and Texas red-labeled sheep anti–mouse
IgG, both obtained from Amersham. The slides were examined in a Zeiss
Axioplan fluorescence microscope.
 
Identification of Binding Sites
 
The binding sites on 
 
g
 
-adaptin for 
 
g
 
-synergin and on 
 
g
 
-synergin for
 
g
 
-adaptin were identified using both the yeast two-hybrid system (de-
scribed above) and GST pulldown experiments. The 
 
g
 
-adaptin ear GST
fusion protein has already been described (Seaman et al., 1996) and the
 
a
 
-adaptin ear GST fusion protein (Owen et al., 1999), used as a control,
was a gift from David Owen (MRC Laboratory of Molecular Biology,
Cambridge, UK). The 
 
g
 
-synergin GST fusion proteins were constructed
from the clone isolated in the original two-hybrid library screen. The con-
struct GST-
 
g
 
s1 contains the rat sequence corresponding to amino acids
168–517 of the human sequence (but missing amino acids 197–274, pre-
sumably because of alternative splicing), the construct GST-
 
g
 
s2 contains
the rat sequence corresponding to amino acids 385–661 of the human
sequence, and the construct GST-
 
g
 
s3 contains the rat sequence corre-
sponding to amino acids 518–786 of the human sequence. The construct
GST-EH contains the EH domain and several amino acids on either side
of it, corresponding to amino acids 188–390 of the human sequence (but
missing amino acids 197–274). All of the constructs were soluble and were
prepared as previously described (Page and Robinson, 1995). For the GST
pulldown experiments, 1 ml of rat liver cytosol prepared in PBS contain-
ing 0.1% NP-40 and a protease inhibitor cocktail (Complete Mini; Boeh-
ringer Mannheim) at a protein concentration of 1.5 mg/ml was first pre-
cleared by incubating for 8 h at 4
 
8
 
C on a rotating wheel with 10 
 
m
 
g GST
and 60 
 
m
 
l of a 50% suspension of glutathione-Sepharose 4B (Pharmacia).
The samples were incubated with 10 
 
m
 
g of the appropriate fusion protein
and 60 
 
m
 
l of the 50% suspension of glutathione-Sepharose overnight at
4
 
8
 
C. The beads were pelleted, washed five times in PBS containing 0.1%
NP-40, eluted with SDS-PAGE sample buffer, and subjected to SDS-
PAGE and Western blotting.
A blot overlay assay was used to demonstrate that 
 
g
 
-adaptin and 
 
g
 
-syn-
ergin bind directly to each other. First, the insert from the GST-
 
g
 
s3 con-
struct was ligated in-frame into the vector pQE30 to introduce a histidine
tag at the NH
 
2 
 
terminus (Qiagen). Expression and purification of the re-
sulting His-
 
g
 
s3 construct were carried out as instructed by the manufac-
turer. A control construct, His-DHFR (supplied with the kit), was also ex-
pressed and purified. Equivalent amounts of the two His-tagged fusion
proteins were subjected to SDS-PAGE and blotted onto a nitrocellulose
membrane, and the blot was blocked with 20 mM Tris-HCl, pH 7.5,
150 mM NaCl, 0.05% Tween 20, 0.5% BSA, 3 
 
m
 
M reduced glutathione for
30 min. This buffer was used in all the following steps. The blot was in-
cubated with 10 nM GST or 
 
g
 
-ear-GST for 45 min, washed for 30 min,
and then labeled as described above using anti-GST followed by 
 
125
 
I–pro-
tein A.
 
Results
 
Isolation of Clones Expressing 
 
g
 
-Adaptin
Interacting Proteins
 
Full-length mouse 
 
g
 
-adaptin cDNA was used as bait to
screen a yeast two-hybrid library containing inserts de-
rived from rat brain cDNA. Out of 
 
z
 
6 
 
3
 
 10
 
6
 
 transfor-
mants, 62 clones were isolated that exhibited a strong and
specific interaction between the 
 
g
 
-adaptin construct and
the library construct. To determine the identity of each of
the 62 clones, both colony blotting and sequencing were
carried out. The results are shown in Table I.
Six of the clones were found to contain plasmids encod-
ing 
 
s
 
1 (
 
s
 
1A), the small chain subunit of the AP-1 adaptor
complex. We have previously shown that 
 
s
 
1 and 
 
g
 
-adaptin
interact strongly in the yeast two-hybrid system, so the iso-
lation of a 
 
s
 
1-encoding plasmid confirmed that the library
screen had worked (Page and Robinson, 1995). Another
six plasmids were found to encode a protein closely re-
lated to 
 
s
 
1, with 87% amino acid identity. This protein has
been independently identified by Takatsu et al. (1998)
and named 
 
s
 
1B. Eleven plasmids were found to encode
 
b
 
-spectrin. The significance of this interaction is at present
unclear (see Discussion). The other 39 plasmids were
found to encode two unknown proteins, and these cDNAs
were subjected to further analysis.
The first of the two unknown cDNAs was isolated with
very high frequency in the two-hybrid screen, accounting
for more than half of all the clones. A representative clone
with an insert of 
 
z
 
2.5 kb was sequenced and was found to
encode a protein of 315 amino acids with a deduced size of
 
z
 
34 kD (p34) (Fig. 1 a). There are several mammalian
ESTs in the database encoding p34, but no homologues
were found that might help to establish the protein’s func-
tion. Northern blotting demonstrated that p34 is expressed
ubiquitously and that the mRNA has a size of 
 
z
 
2.75 kb
(Fig. 1 b). Unlike most of the other proteins identified in
the screen, p34 was found to interact not only with 
 
g
 
-adap-
tin but also with 
 
a
 
-adaptin in the two-hybrid system, and
this interaction was mapped to the NH
 
2
 
-terminal domains
of the two adaptins (Fig. 1 c). Attempts were made to raise
antisera against p34, but unfortunately the protein proved
to be a very poor antigen. Thus, although two different do-
mains were expressed as fusion proteins for antibody pro-
duction, and although the resulting antisera were affinity-
purified, all of the antisera labeled multiple bands on
Western blots. However, one of the antisera labeled a
band of around the expected size (
 
z
 
37 kD), and this pro-
tein could be immunoprecipitated in substoichiometric
amounts with cytosolic AP-1 and AP-2, suggesting that the
interactions detected in the two-hybrid system are physio-
logically relevant (data not shown). But because we were
looking for proteins that interact specifically with the AP-1
complex, p34 was not characterized further.
 
g
 
-Synergin: Sequence and Splicing
 
The other unknown cDNA came up with the least fre-
quency in the library screen, accounting for only one of the
clones. Northern blotting showed that the transcript is ex-
pressed ubiquitously and has a size of 
 
z
 
4.4–5.6 kb, with
bands of different mobilities labeled in different tissues
Table I. List of Proteins Identified in the Two-hybrid Screen
Proteins identified in
yeast two-hybrid screen Number isolated
s1A 6
s1B 6
b-spectrin 11
p34 38
g-synergin 1
A combination of colony blotting and/or sequencing was used to determine the iden-
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(Fig. 2 a). The original clone contained an insert of only
z1.6 kb and the sequence appeared to be all open reading
frame, so this clone was used as a probe to screen a rat
brain lgt10 cDNA library to try to obtain a full-length se-
quence. Three additional clones were isolated and se-
quenced (Fig. 2 b). A comparison of the four sequences re-
vealed that the mRNA is alternatively spliced, consistent
with the heterogeneity seen on the Northern blot. A puta-
tive start was identified in one of the clones, but none of
the clones had an in-frame stop codon at the 39 end. How-
ever, when the EST database was searched with the rat se-
quences, three human sequences were found, and from the
corresponding cDNAs it was possible to assemble a con-
tiguous human open reading frame. The nonredundant da-
tabase was also searched with both the rat and the human
sequences, and the human genomic sequence encoding the
39 end of the mRNA was found. Fig. 2 c shows the ge-
nomic structure, including the alternative splice sites.
An analysis of the open reading frame revealed that the
protein contains an EH domain at amino acids 295–377
(Figs. 2 d and 3 b). EH domains, which bind to proteins
containing the sequence NPF, have now been found in a
large number of proteins, including the mammalian pro-
teins Eps15, Ese1, and Ese2, and the yeast proteins End3p
and Pan1p, all of which are involved in endocytosis (Di
Fiore et al., 1997). g-Adaptin contains no NPF sequences,
so it is likely that the novel protein serves as a linker be-
tween g-adaptin and some other unidentified protein. We
propose that this protein be called g-synergin (from the
Greek, synergos, meaning partner or workmate).
A schematic diagram of g-synergin is shown in Fig. 3 a,
indicating the positions of the EH domain, some of the al-
ternative splice sites, and the g-adaptin–binding domain
(see below). Fig. 3 b shows an alignment of the EH do-
mains from g-synergin, Eps15, Ese1, End3p, and Pan1p.
The EH domain of g-synergin can be seen to contain all of
the highly conserved amino acids found in other, well
characterized EH domains. However, apart from the EH
domain, g-synergin shows no significant sequence homol-
ogy to any other proteins in the database, and it does not
share any of the other features found in the a-adaptin
binding partner Eps15 such as a coiled-coil domain or a
proline-rich region.
g-Synergin: Association with AP-1 In Vivo
To learn more about the function of g-synergin, the origi-
nal clone identified in the two-hybrid library screen was
Figure 1. Characterization of
p34. (a) Protein sequence de-
duced from the cDNA se-
quence. The identification of
the initiator methionine is
based on two observations:
first, it is preceded by a
Kozak sequence; and second,
none of the clones, either
from the original library
screen or from a subsequent
screen of a lgt10 cDNA li-
brary, extended any further
in the 59 direction. (b) North-
ern blot. A rat multiple tissue
Northern blot was probed
with the insert from one of
the clones isolated in the two-
hybrid library screen, which
contains the complete coding
sequence for p34. (c) p34 in-
teracts with both g and a in
the two-hybrid system. The
NH2-terminal domains of
both  g-adaptin and a-adaptin
were cloned into the two-
hybrid bait vector pGBT9
and coexpressed with either
the prey vector pGAD424
with no insert (control) or
with the prey vector pGAD10
containing the coding se-
quence for p34. Colonies
were assayed for the expres-
sion of b-galactosidase. Cells
expressing p34 in pGAD10
alone  produced no detect-
able b-galactosidase.Page et al. g-Synergin, a g-Adaptin–binding Protein 997
expressed as a fusion protein for antibody production. Fig.
4 shows a Western blot of equal protein loadings of homog-
enate from both brain and liver as well as various subcellu-
lar fractions from liver probed with the affinity-purified
antibody. Two bands are labeled in the brain of z110 and
z150 kD, whereas in the liver, a single band is labeled of
z190 kD. This is consistent with the Northern blot (Fig. 2
a) in which a single band was labeled in liver, whereas two
bands were labeled in brain, indicating that the different
protein species might represent different spliced variants,
although we cannot rule out the possibility that the differ-
ences might also be due to proteolysis. g-Synergin is found
in both a high speed supernatant and membrane-contain-
ing pellet, indicating that it is peripherally associated with
membranes. It is somewhat enriched in a TGN-enriched
fraction from liver and it is strongly enriched in liver clath-
rin-coated vesicles.
The association between g-synergin and g-adaptin was
Figure 2. Characterization of
g-synergin at the nucleic acid
level. (a) Northern blot. A rat
multiple tissue Northern blot
was probed with the insert from
the clone isolated in the two-
hybrid library screen. Different
sized bands are labeled in differ-
ent tissues, indicative of alterna-
tive splicing. (b) Diagram of the
protein sequence of g-synergin,
showing the open reading frame,
the three human ESTs used in
the assembly of the full-length
sequence, the partial genomic se-
quence (after splicing), the origi-
nal clone isolated in the two-
hybrid library screen, and the
three clones isolated from a sub-
sequent screen of a rat brain
lgt10 cDNA library. The rat
clones isolated differ from the
human sequence near their NH2
termini in missing amino acids
197–274. Although there is no
genomic sequence available for
this region, this difference is
likely to be due to alternative
splicing. The 39 end of rat clone 1
has sequence homologous to the
human intron between exons 1
and 2 (see c) and is, therefore, ei-
ther an incompletely spliced pre-
cursor or an alternatively spliced
mRNA. Rat clone 3 uses the al-
ternative splice site between ex-
ons 1 and 2 indicated in c with an
additional four amino acids that
could be the result of an addi-
tional exon or a difference be-
tween the rat and human se-
quence at splice junctions. (c)
Diagram of the human g-syner-
gin gene. Exon and intron junc-
tions are shown for the 39 region
where the genomic sequence is
known. Hatched regions repre-
sent sequence derived solely
from cDNA clones. The sizes of
the predicted introns (in kb) are indicated. The two alternative polyadenylation sites were determined from human ESTs in the data-
base. (d) Deduced protein sequence of human g-synergin. Amino acid 1,123 is ambiguous because of a single base difference between
the submitted genomic sequence and our own cDNA sequence, and is either an E in the former or a K in the latter. The identification of
the putative initiator methionine is based on the observation that it is preceded by a Kozak sequence and on the finding that there are
three short (,500 bp), internally primed g-synergin sequences in the EST database, none of which extends any further in the upstream
direction than EST 510825. The EH domain of the protein is highlighted. The rat and human sequences have 85% amino acid identity
overall, and 98% identity in the EH domain. These sequence data are available from GenBank/EMBL/DDBJ under accession numbers
AF169548 (human sequence) and AF169549 (rat sequence).The Journal of Cell Biology, Volume 146, 1999 998
confirmed by immunofluorescence microscopy. Double
labeling of MDBK cells with anti–g-synergin and anti–
g-adaptin revealed a striking degree of colocalization of
the two proteins (Fig. 5, a and b). Next, we investigated
whether the membrane association of g-synergin is af-
fected by the drug brefeldin A (BFA). This drug causes
ARF to dissociate rapidly from membranes (Donaldson et
al., 1992; Helms and Rothman, 1992), leading to the disso-
ciation of other peripheral membrane proteins whose
membrane association is ARF-dependent, such as the AP-1
adaptor complex (Robinson and Kreis, 1992). In Fig. 5, c
and d, MDBK cells were treated with BFA for 2 min, and
then double labeled for g-synergin (c) and g-adaptin (d).
Both proteins can be seen to have redistributed to the cy-
toplasm. To examine the behavior of the two proteins
upon BFA washout, we treated cells with the drug for 30
min, and then allowed them to recover for 2 min (Fig. 5, e
and f). Both proteins can be seen to have reassociated with
the membrane, which now has a more tubular appearance
as a result of the BFA treatment. Thus, g-synergin, like the
AP-1 adaptor complex, appears to associate with the TGN
membrane in an ARF-dependent manner.
The immunofluorescence data demonstrate that g-syn-
ergin is associated with AP-1 on TGN membranes. To find
out whether the two proteins are also associated in the cy-
tosol, immunoprecipitations were carried out under non-
denaturing conditions (Fig. 6). Rat liver cytosol was immu-
noprecipitated with anti–g-adaptin followed by protein
A–Sepharose, and Western blots were probed with anti–
g-synergin or anti–g-adaptin. As a control, cytosol was
also immunoprecipitated with anti–a-adaptin. Cytosolic
g-synergin was found to coprecipitate with g-adaptin but
not with a-adaptin. Thus, g-synergin is associated with
AP-1 in the cytosol as well as on membranes.
Identification of Binding Domains
To identify the domain on g-adaptin that binds to g-syner-
gin and the domain on g-synergin that binds to g-adaptin,
two approaches were used: yeast two-hybrid analysis and
GST pulldown experiments. The NH2-terminal domain
construct of g-adaptin, which was found to interact with
p34 in the two-hybrid system (Fig. 1 c), did not interact
with g-synergin nor did a g-adaptin construct with the
a-adaptin ear, indicating that g-synergin binds to the ear
domain of g-adaptin (data not shown). This was confirmed
using GST fusion proteins to isolate binding partners in rat
liver cytosol, followed by Western blotting and probing
with anti–g-synergin. Fig. 7 a shows that GST fused to the
Figure 3. Characteristics of
g-synergin. (a) The sche-
matic diagram shows the po-
sitions of the alternative
splice sites (AS), EH domain,
g-adaptin–binding domain,
and DDFD/EXF sequences
(D). (b) Comparison of the
EH domain of g-synergin
with that of several well char-
acterized EH domain-con-
taining proteins: the mamma-
lian proteins Eps15 and Ese1,
and the yeast proteins Pan1p
and End3p.
Figure 4. SDS-PAGE and Western blot probed with anti–g-syn-
ergin. The samples, from left to right, are: pig brain homogenate,
rat liver homogenate, rat liver high speed supernatant (cytosol),
rat liver high speed pellet, rat liver TGN-enriched fraction,
and rat liver clathrin-coated vesicles. The blot shows that g-syn-
ergin is a peripheral membrane protein that is highly enriched in
clathrin-coated vesicles. The different patterns seen in brain and
liver may be due to alternative splicing.Page et al. g-Synergin, a g-Adaptin–binding Protein 999
Figure 5. g-Synergin colocalizes with g-adaptin by immunofluorescence. MDBK cells were double labeled with anti–g-synergin (a, c,
and e) and anti–g-adaptin (b, d, and f) either under control conditions (a and b), after incubating with brefeldin A for 2 min (c and d), or
after incubating with brefeldin A for 30 min and allowing the cells to recover for 2 min (e and f). Bar, 20 mm.The Journal of Cell Biology, Volume 146, 1999 1000
g-adaptin ear binds g-synergin, whereas GST alone or
GST fused to the a-adaptin ear do not.
The same general strategy was used to identify the do-
main of g-synergin that binds to g-adaptin. Four sets of
constructs were made from the original g-synergin clone
isolated in the two-hybrid library screen: one containing
just the EH domain (GST-EH); one containing the NH2-
terminal half, including the EH domain (GSTgs-1, corre-
sponding to amino acids 168–517 of the human sequence
but missing amino acids 197–274, presumably because of
alternative splicing); one containing the middle portion of
the protein (GSTgs-2, amino acids 385–661); and one con-
taining the COOH-terminal half (GSTgs-3, amino acids
518–786). Only the construct containing the more COOH-
terminal portion of g-synergin (GSTgs-3) bound g-adaptin
in the GST pulldown experiments (Fig. 7 b), and this inter-
action was confirmed using the two-hybrid system (data
not shown).
The GST pulldown experiments were carried out using
whole cytosol, and, thus, they cannot distinguish between
a direct interaction between g-synergin and g-adaptin and
an indirect one, mediated by another protein or proteins.
The ability of the two proteins to interact in the yeast two-
hybrid system strongly suggests that the interaction is di-
rect, but to prove this formally, we also carried out West-
ern blot overlay experiments, a technique that has been
used to demonstrate that the a-adaptin ear domain binds
directly to proteins such as amphiphysin and epsin (Chen
et al., 1998; Owen et al., 1999). For these experiments, the
portion of g-synergin that contains the g-adaptin–binding
domain, amino acids 518–786, was expressed as a histi-
dine-tagged construct (His-gs3) and purified on a nickel
affinity column. A control histidine-tagged construct was
also expressed and purified (His-control). The two con-
structs were subjected to SDS-PAGE, blotted, and probed
either with GST alone followed by anti-GST, with GST-g
ear followed by anti-GST, or with anti–g-synergin. Fig. 7 c
shows that the GST-g ear construct, but not GST alone,
binds to the His-gs3 band on the Western blot. Thus, the
interaction between g-adaptin and g-synergin must be a
direct one. The binding site on g-synergin for g-adaptin is
indicated in Fig. 3 a.
g-Synergin Follows AP-1 onto the Membrane
We have previously shown that the COOH-terminal ear
domains of g- and a-adaptin contain weak targeting sig-
nals for recruitment onto the TGN and plasma mem-
branes, respectively (Robinson, 1993; Page and Robinson,
1995). Thus, a construct containing mostly a-adaptin, but
with the g-adaptin COOH-terminal domain, coassembles
with the three subunits normally found in the AP-2 com-
plex and is mainly associated with the plasma membrane,
although a small fraction is seen on the TGN. Similarly, a
construct containing mostly g-adaptin, but with the a-adap-
tin COOH-terminal domain, coassembles with the subunits
Figure 6. g-Synergin is associated with AP-1 in the cytosol. Rat
liver cytosol was immunoprecipitated with either anti–g-adaptin
or anti–a-adaptin, and Western blots were probed as indicated
with either anti–g-synergin, anti–g-adaptin, or anti–a-adaptin.
The lower molecular mass band (z165 kD) labeled with the anti–
g-synergin antibody is probably a breakdown product of the pro-
tein.
Figure 7. Identification of binding sites on g-synergin and
g-adaptin. (a, left to right) Rat liver cytosol was incubated with
GST alone, with a GST fusion protein containing the a-adaptin
ear domain, or with a GST fusion protein containing the g-adap-
tin ear domain, followed by glutathione-Sepharose. The Western
blot was probed with anti–g-synergin. The g-synergin can be seen
to bind specifically to the ear domain of g-adaptin. (b, left to
right) Rat liver cytosol was incubated with GST alone, with a
GST fusion protein containing the EH domain of g-synergin,
with a GST fusion protein containing amino acids 168–517 of
g-synergin (but missing amino acids 197–274, presumably because
of alternative splicing) (GST-gs1), with a GST fusion protein
containing amino acids 385–661 of g-synergin (GST-gs2), or with
a GST fusion protein containing amino acids 518–786 of g-syner-
gin (GST-gs3), followed by glutathione-Sepharose. The Western
blot was probed with anti–g-adaptin. Only the GST-gs3 construct
pulls down g-adaptin. (c) Two histidine-tagged constructs, one
containing the same domain of g-synergin as the fusion protein
gs3 (His-gs3) and a control construct, histidine-tagged DHFR
(His-control), were subjected to SDS-PAGE followed by West-
ern blotting. The blots were probed with either GST followed by
anti-GST, GST coupled to the g-adaptin ear domain (GST-gear)
followed by anti-GST, or anti–g-synergin. A band of z45 kD,
corresponding to His-gs3, can be seen to be labeled in the GST-
gear overlay.Page et al. g-Synergin, a g-Adaptin–binding Protein 1001
normally found in the AP-1 complex and is mainly associ-
ated with the TGN, although a small fraction is seen on the
plasma membrane.
We and others have long been interested in identifying
the membrane docking sites for coat proteins, and although
it is clear that g-synergin cannot be the only docking site
for AP-1, since the a-adaptin chimera with the g-adaptin
ear goes mainly to the plasma membrane, it is possible that
it might participate in AP-1 recruitment. Alternatively,
g-synergin may be localized to the TGN because of its as-
sociation with AP-1 rather than vice versa. To distinguish
between these two possibilities, i.e., to determine whether
g-synergin leads AP-1 onto the TGN or follows it there,
we examined the distribution of g-synergin in cells ex-
pressing a chimera consisting of the a-adaptin NH2-termi-
nal domain with the g-adaptin hinge and ear (agg). If
g-synergin helps to recruit AP-1, we would expect its dis-
tribution to be unchanged in such cells, However, if AP-1
recruits g-synergin, we would expect some of the g-syner-
gin to be rerouted to the plasma membrane. Fig. 8 clearly
shows that the latter is the case. In the transfected cell ex-
pressing the chimeric adaptin, much of the g-synergin la-
beling shows the characteristic punctate plasma mem-
brane pattern (b), colocalizing with the chimera (a). Thus,
g-synergin follows AP-1 onto the appropriate membrane
rather than leading it there.
Discussion
The yeast two-hybrid system has proved to be a powerful
way of investigating protein–protein interactions that may
be difficult to study by more conventional biochemical
methods. Among the advantages of the two-hybrid system
are that it can detect interactions that may occur only tran-
siently in the cell, and that it can be used not only to iden-
tify but also to clone the binding partners of a protein of
interest. Its disadvantages are that it sometimes fails to
pick up protein–protein interactions that normally occur
in the cell, while at the same time revealing interactions
that may occur in the two-hybrid system, but not under
more physiological conditions. In the present study, we
have used this approach to search for g-adaptin binding
partners and have cloned cDNAs encoding five different
proteins: s1A, s1B, b-spectrin, p34, and g-synergin.
The cloning of s1A acts as a positive control, since we
previously showed that it interacts strongly with g-adaptin
in the two-hybrid system (Page and Robinson, 1995). The
finding that s1B also binds to g-adaptin is consistent with
the findings of Takatsu et al. (1998), who also found that
both isoforms of s1 can interact with the same isoform of
g. Northern blotting reveals that both isoforms of s1 are
expressed ubiquitously (Takatsu et al., 1998, and our own
unpublished results). Although we attempted to raise
monospecific antibodies that recognize s1B but not s1A
by immunizing and cross-absorbing with different fusion
proteins, so far we have not succeeded, presumably be-
cause of the high degree of homology between the two
proteins. Thus, at present we do not know whether there
are any functional differences between the two s1 iso-
forms.
In our previous study in which we investigated interac-
tions between neighboring adaptor subunits using the two-
hybrid system, we found that g-adaptin binds not only to
s1, but also to b1 and (to a lesser extent) to b2 (Page and
Robinson, 1995). However, we did not pick up either of
the two b-adaptins in the library screen. This appears to
be because under the more stringent conditions used
to screen a two-hybrid library, the interaction between
g-adaptin and b1 or b2 is not strong enough to produce a
signal (data not shown). Another potential g-adaptin bind-
ing partner is p75, which can be cross-linked to membrane-
associated g-adaptin (Seaman et al., 1996). However, none
of the proteins that we identified in the screen has a
molecular mass of z75 kD. It is not clear why we
failed to clone this protein, but one possibility is that the
interaction between p75 and g-adaptin does not occur
Figure 8. Localization of g-syner-
gin in cells expressing an adaptin
chimera. Cells expressing a con-
struct consisting of the NH2-termi-
nal domain of a-adaptin, the hinge
domain of g-adaptin, and the ear
domain of g-adaptin (agg) were
double labeled with an antibody
specific for the construct (a) and
anti–g-synergin (b). In the trans-
fected cell, much of the g-synergin
has been redirected to the plasma
membrane where it colocalizes with
the construct. Bar, 20 mm.The Journal of Cell Biology, Volume 146, 1999 1002
when the two are expressed as fusion proteins in yeast
(e.g., if p75 only interacts with g-adaptin when it is incor-
porated into the AP-1 complex). Alternatively, if p75 is an
integral membrane protein, the presence of a transmembrane
domain may prevent it from entering the nucleus, which is
where it must be to be detected by the two-hybrid system.
The cloning of b-spectrin was unexpected and it is not
yet clear whether its interaction with g-adaptin is physio-
logically relevant. Although spectrin was initially assumed
to be associated only with the plasma membrane, a num-
ber of immunofluorescence studies using certain antibod-
ies against erythrocyte b-spectrin have indicated that an
isoform of the protein is associated with the Golgi appara-
tus, and recently a novel member of the b-spectrin family,
bIII spectrin, was cloned and localized to the Golgi region
of the cell (Stankewich et al., 1998). However, sequencing
indicates that the b-spectrin isoform that we cloned as a
g-adaptin binding partner is not bIII spectrin but bII spec-
trin, which has been localized to the plasma membrane.
Future studies should show whether g-adaptin can bind to
bIII spectrin as well as to bII spectrin, and whether the
two proteins can associate with each other in the cell.
The protein that came up most frequently in the screen,
p34, is unusual in that it interacts with both g-adaptin and
a-adaptin. This interaction was mapped to the NH2-termi-
nal domains of the two adaptins, which is where g and a
show the most homology, although even here they are
only 32% identical. Another clue as to the function of p34
comes from the observation that it can be coimmunopre-
cipitated with soluble adaptor complexes, both AP-1 and
AP-2, although it is not enriched in purified clathrin-
coated vesicles. This suggests that p34 may play some sort
of chaperone role. For instance, it could help to prevent
the soluble adaptors from coassembling with soluble clath-
rin, or it could participate in uncoating by helping to re-
move the adaptors from the coated vesicle. Another possi-
bility is that p34 may aid in the recruitment of soluble
adaptors onto the membrane. However, it is clear that it
cannot be involved in the specificity of adaptor recruit-
ment, since it appears to interact equally well with both
adaptor complexes.
Potentially the most interesting of the proteins that we
isolated is g-synergin. This protein colocalizes with AP-1
by immunofluorescence, and it can be coimmunoprecipi-
tated with cytosolic AP-1. It binds specifically to the
COOH-terminal ear domain of g-adaptin, the same do-
main that, on a-adaptin, binds to at least three different
partners. The COOH-terminal ear domains of both g and
a have also been implicated in the recruitment of the AP-1
and AP-2 complexes onto their respective membranes, al-
though the major targeting information appears to reside
in the adaptor heads. However, g-synergin is a peripheral
membrane protein, not an integral membrane protein; its
sensitivity to BFA indicates that it associates with the
TGN in an ARF-dependent manner, and we have previ-
ously shown that the only soluble proteins required for
AP-1 recruitment are the AP-1 itself and ARF-1 (Seaman
et al., 1996). In addition, in cells expressing a-adaptin with
the  g-adaptin ear, a construct that goes mainly to the
plasma membrane, a substantial amount of the g-synergin
also goes to the plasma membrane. These observations in-
dicate that g-synergin is recruited onto the membrane
through its interaction with AP-1 rather than vice versa,
and, thus, that it does not play any part in targeting the
AP-1 complex to the appropriate membrane.
What, then, is the function of g-synergin? The presence
of an EH domain indicates that, like Eps15 (the first EH
domain-containing protein to be characterized) it is an
adaptor for an adaptor. Eps15 interacts with the ear do-
main of the a-adaptin subunit of the AP-2 complex (Ben-
merah et al., 1995) although, like g-synergin, its adaptin
binding site is distinct from its EH domain. The a-adaptin
binding site on Eps15 is quite large, comprising over 100
amino acids and including multiple repeats of the tripep-
tide DPF (Benmerah et al., 1998). The g-adaptin binding
site on g-synergin shows no homology to the a-adaptin
binding site on Eps15, and no DPF sequences are present
in g-synergin. However, it may be relevant that there are
five repeats of the sequence DDFXD/EF, three of which
(at positions 668–673, 689–694, and 774–779) are within
amino acids 518–786, which we mapped as the g-adaptin
binding site (Fig. 3 a, the repeats are marked D). The
other two copies of this sequence are outside of this region
(456–461 and 1022–1027); however, preliminary evidence
suggests that the true g-adaptin binding site may encom-
pass more than amino acids 518–786. Although only the
construct containing this sequence interacted with the
g-adaptin ear domain in GST pulldown experiments,
when interactions between g-adaptin and g-synergin were
assayed using the two-hybrid system, clones containing
amino acids 168–517 and 385–661 as well as 518–786, but
not the clone containing the EH domain alone, produced
positive results (data not shown). We now intend to inves-
tigate whether the DDFXD/EF sequence is required for
g-adaptin binding.
How much of the g-adaptin and g-synergin in the cell
are associated with each other? Western blots of AP-1 im-
munoprecipitated from cytosol under nondenaturing con-
ditions show that g-synergin coprecipitates (Fig. 6); how-
ever, under conditions where AP-1 subunits can be seen
by Coomassie blue staining, no g-synergin band can be
seen, indicating that the interaction is substoichiometric
(Sowerby, P.J., and M.S. Robinson, unpublished observa-
tion). When we immunoprecipitate g-synergin under
nondenaturing conditions, we are unable to detect any
g-adaptin by Western blotting (Sowerby, P.J., and M.S.
Robinson, unpublished observations). This is presumably
because the anti–g-synergin antibody, which was raised
against the portion of the protein that we isolated in the
two-hybrid screen, binds to the same site on g-synergin as
g-adaptin. Thus, it is clear that although some of the AP-1
and g-synergin are associated with each other in the cyto-
sol, there are also unoccupied pools of both proteins. At
present, we do not know whether the g-synergin and AP-1
that are associated with each other are stably bound, or
whether the interaction is more dynamic.
In addition to its association with g-adaptin, we would
predict that g-synergin has at least one additional binding
partner, which would interact with its EH domain. So far,
attempts to screen a yeast two-hybrid library with the EH
domain of g-synergin have been unsuccessful, nor have we
identified any candidates by GST pulldown or blot overlay
experiments using the g-synergin EH domain. However,
when we have carried out GST pulldown experiments withPage et al. g-Synergin, a g-Adaptin–binding Protein 1003
the g-adaptin ear construct, we find that other proteins
come down in addition to g-synergin (Liu, W.W., P.J.
Sowerby, and M.S. Robinson, unpublished observations),
which could interact either directly with g-adaptin or indi-
rectly, via g-synergin or another g ear binding partner. We
now intend to identify and characterize these proteins, to
see whether they are related to any of the AP-2 interacting
proteins, or whether they contain NPF sequences. One po-
tential (indirect) g-adaptin binding partner might be an
isoform or homologue of dynamin, such as dynamin 2,
which has been implicated in trafficking from the TGN
(Cao et al., 1998; Jones et al., 1998; but see also Altschuler
et al., 1998). However, the lack of sequence homology be-
tween the g ear and the a ear (Robinson, 1990) suggests
that there may also be binding partners that are entirely
specific for one or the other of the two AP complexes.
Some of the proteins associated either directly or indi-
rectly with AP-2, including Eps15 (Benmerah et al., 1998),
amphiphysin (Wigge et al., 1997), dynamin (Damke et al.,
1994), and epsin (Chen et al., 1998), have been used to cre-
ate dominant negative mutants by overexpressing trun-
cated or mutated forms of the protein. Thus, for instance,
a construct consisting of just the a-adaptin binding por-
tion of Eps15 is a potent inhibitor of clathrin-mediated en-
docytosis (Benmerah et al., 1998). It should be possible to
use the same strategy with g-synergin. Preliminary ex-
periments in which we transiently transfected cells with a
truncated form of g-synergin, consisting of amino acids
168–786 (the original two-hybrid clone), indicate that this
construct is toxic to cells, so we are now developing induc-
ible systems. These studies should help to define both the
role of g-synergin and the role of the AP-1 pathway in
general. Although there is abundant evidence that AP-1 is
involved in the trafficking of newly synthesized lysosomal
proteins from the TGN to an endosomal or prelysosomal
compartment, it may have other functions as well. AP-1
has been localized not only to the TGN, but also to early/
recycling endosomes (Futter et al., 1998) and (in cells with
a regulated secretory pathway) to immature secretory
granules (Dittie et al., 1996; Klumperman et al., 1998), and
it has been proposed that it may participate not only in
trafficking to prelysosomes, but also in transcytosis (Futter
et al., 1998), the recycling of proteins from the endosome
back to the plasma membrane (Futter et al., 1998), trans-
port from the early endosome to the TGN (Mallard et al.,
1998), and the removal of nongranule proteins from the
immature secretory granule (Dittie et al., 1996; Klumper-
man et al., 1998). Another possibility is that the AP-1
pathway may be used to transport not only lysosomally di-
rected proteins, but also some of the proteins destined for
the plasma membrane, from the TGN to an endosomal
compartment. It has also been proposed that AP-1 may
play a specialized role in polarized epithelial cells, and in-
terestingly there is an isoform of the m1 subunit, m1B,
which is expressed exclusively in epithelial cells and tissues
(Ohno et al., 1999). So far, most of our knowledge of the
AP-1 pathway has come from immunolocalization and in
vitro binding experiments. If we can inactivate the AP-1
pathway experimentally, it should be possible to carry out
the same types of functional studies, making use of living
cells, that have been so informative in the case of AP-2
and AP-3.
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